Kay Robert 4/A
4/A · iBio, Inc. · Filed Oct 28, 2020
Insider Transaction Report
Form 4/AAmended
iBio, Inc.IBIO
KAY ROBERT
DirectorExecutive Chairman and CEO
Transactions
- Award
Stock Option
2020-06-12+400,000→ 400,000 totalExercise: $1.57From: 2020-06-12Exp: 2030-06-12→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]This amendment on Form 4/A is being filed to amend the original Form 4 filed by the reporting person on June 16, 2020 (the "Original Form 4") solely to amend the exercise price in Column 2 of Table II which was incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.
- [F2]Immediate vesting as to 50,000 shares of Common Stock underlying the option and the remaining shares vest pro rata on a monthly basis over the next 21 months.